HUE054792T2 - Protein kináz inhibitorokként hasznos piridokinazolin származékok - Google Patents

Protein kináz inhibitorokként hasznos piridokinazolin származékok

Info

Publication number
HUE054792T2
HUE054792T2 HUE18759146A HUE18759146A HUE054792T2 HU E054792 T2 HUE054792 T2 HU E054792T2 HU E18759146 A HUE18759146 A HU E18759146A HU E18759146 A HUE18759146 A HU E18759146A HU E054792 T2 HUE054792 T2 HU E054792T2
Authority
HU
Hungary
Prior art keywords
pyridoquinazoline
derivatives
useful
protein kinase
kinase inhibitors
Prior art date
Application number
HUE18759146A
Other languages
English (en)
Hungarian (hu)
Inventor
Guido Kurz
Gomez Juan Camacho
Original Assignee
Oncostellae S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncostellae S L filed Critical Oncostellae S L
Publication of HUE054792T2 publication Critical patent/HUE054792T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F24HEATING; RANGES; VENTILATING
    • F24CDOMESTIC STOVES OR RANGES ; DETAILS OF DOMESTIC STOVES OR RANGES, OF GENERAL APPLICATION
    • F24C7/00Stoves or ranges heated by electric energy
    • F24C7/08Arrangement or mounting of control or safety devices
    • F24C7/082Arrangement or mounting of control or safety devices on ranges, e.g. control panels, illumination
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F24HEATING; RANGES; VENTILATING
    • F24CDOMESTIC STOVES OR RANGES ; DETAILS OF DOMESTIC STOVES OR RANGES, OF GENERAL APPLICATION
    • F24C7/00Stoves or ranges heated by electric energy
    • F24C7/08Arrangement or mounting of control or safety devices
    • F24C7/087Arrangement or mounting of control or safety devices of electric circuits regulating heat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Combustion & Propulsion (AREA)
  • Mechanical Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HUE18759146A 2017-06-01 2018-05-31 Protein kináz inhibitorokként hasznos piridokinazolin származékok HUE054792T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201730759 2017-06-01

Publications (1)

Publication Number Publication Date
HUE054792T2 true HUE054792T2 (hu) 2021-09-28

Family

ID=61569288

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE18759146A HUE054792T2 (hu) 2017-06-01 2018-05-31 Protein kináz inhibitorokként hasznos piridokinazolin származékok

Country Status (22)

Country Link
US (1) US11021479B2 (enExample)
EP (1) EP3632912B1 (enExample)
JP (1) JP7110335B2 (enExample)
KR (1) KR102629854B1 (enExample)
CN (1) CN111247143B (enExample)
AU (1) AU2018278283B2 (enExample)
CA (1) CA3066009A1 (enExample)
CY (1) CY1124087T1 (enExample)
DK (1) DK3632912T3 (enExample)
EA (1) EA037384B1 (enExample)
ES (1) ES2881960T3 (enExample)
HR (1) HRP20210814T1 (enExample)
HU (1) HUE054792T2 (enExample)
LT (1) LT3632912T (enExample)
MX (1) MX385475B (enExample)
PL (1) PL3632912T3 (enExample)
PT (1) PT3632912T (enExample)
RS (1) RS61833B1 (enExample)
SI (1) SI3632912T1 (enExample)
SM (1) SMT202100312T1 (enExample)
WO (1) WO2018220252A1 (enExample)
ZA (1) ZA201908372B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7525609B2 (ja) 2020-01-31 2024-07-30 エルジー エナジー ソリューション リミテッド 多層構造の無機物層を含む分離膜一体型電極の製造方法及びそれによる分離膜一体型電極

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4551460A (en) 1982-05-10 1985-11-05 Hoffmann-La Roche Inc. Pyrido[2,1-b]quinazoline derivatives useful as agents for treatment of allergic conditions and vascular disorders involving thrombosis
EP0944628B1 (en) * 1996-11-26 2002-06-05 American Cyanamid Company Hetero-biaryl-pyridoquinazolinone derivatives as anti-cancer agents
US20050171172A1 (en) * 2003-11-13 2005-08-04 Ambit Biosciences Corporation Amide derivatives as PDGFR modulators
AU2008345225A1 (en) * 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
KR101361027B1 (ko) 2008-11-28 2014-02-11 코와 가부시키가이샤 피리딘-3-카르복시아미드 유도체
US11001581B2 (en) 2014-03-20 2021-05-11 The Johns Hopkins University and Lieber Institute, Inc. Compounds which inhibit RNA polymerase, compositions including such compounds, and their use

Also Published As

Publication number Publication date
RS61833B1 (sr) 2021-06-30
EA201992793A1 (ru) 2020-03-26
EA037384B1 (ru) 2021-03-23
HRP20210814T1 (hr) 2021-06-25
CA3066009A1 (en) 2018-12-06
CN111247143B (zh) 2022-07-05
SMT202100312T1 (it) 2021-07-12
EP3632912B1 (en) 2021-03-17
JP7110335B2 (ja) 2022-08-01
ES2881960T3 (es) 2021-11-30
JP2020521817A (ja) 2020-07-27
MX385475B (es) 2025-03-18
CN111247143A (zh) 2020-06-05
US20200148676A1 (en) 2020-05-14
US11021479B2 (en) 2021-06-01
DK3632912T3 (da) 2021-05-10
MX2019014436A (es) 2020-02-10
AU2018278283B2 (en) 2021-06-17
KR20200011990A (ko) 2020-02-04
SI3632912T1 (sl) 2021-08-31
KR102629854B1 (ko) 2024-01-25
CY1124087T1 (el) 2022-05-27
PL3632912T3 (pl) 2021-09-06
LT3632912T (lt) 2021-06-10
PT3632912T (pt) 2021-06-02
EP3632912A1 (en) 2020-04-08
WO2018220252A1 (es) 2018-12-06
AU2018278283A1 (en) 2019-12-19
BR112019024892A2 (pt) 2020-06-16
ZA201908372B (en) 2021-04-28

Similar Documents

Publication Publication Date Title
CY2024003I1 (el) Ενωσεις χρησιμες ως αναστολεις κινασης
LT3768674T (lt) Aminopirimidino dariniai kaip ctps1 inhibitoriai
LT3580220T (lt) Aminotriazolopiridinai, kaip kinazės inhibitoriai
HUE053564T2 (hu) Heterociklusos amidok kinázinhibitorként
LT3497103T (lt) Piridopirimidinono cdk2/4/6 inhibitoriai
DK3303334T3 (da) Tyrosinkinasehæmmere
DK3365334T3 (da) Benzolactamforbindelser som proteinkinaseinhibitorer
PL3218378T3 (pl) Pochodne 6-amino-7-bicyklo-7-deazapuryny jako inhibitory kinaz białkowych
EP3247692A4 (en) INHIBITORS OF TRKA KINASE
DK3571192T3 (da) Jak1-selektive inhibitorer
MA42242A (fr) Inhibiteurs de la tyrosine kinase
DK3642202T3 (da) Dihydro-pyrrolo-pyridin-derivater
LT3704118T (lt) Aminoimidazopiridazinai, kaip kinazės inhibitoriai
EP3684772C0 (en) CYCLIC IMINOPYRIMIDINE DERIVATIVES AS KINASE INHIBITORS
EP3804707A4 (en) KINASE INHIBITOR
DK3288931T4 (da) Visse proteinkinaseinhibitorer
DK3592745T3 (da) Pyrimidopyrimidinoner anvendelige som Wee-1 kinaseinhibitorer
DK3768669T3 (da) Piperazinazaspiroderivater
DK3630744T3 (da) Pyrazol-magl-inhibitorer
DK3625224T3 (da) N-substituerede indolderivater
EP3555092A4 (en) PROTEIN KINASE INHIBITORS
ZA201808014B (en) Adenine derivatives as protein kinase inhibitors
EP3600301A4 (en) KDM4 INHIBITORS
DK3652176T3 (da) Substituerede xanthinderivater
EP3615525C0 (en) PYRROLE DERIVATIVES AS PLK1 INHIBITORS